Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Clinical Cancer Research
Published October 16, 2026
Radiotherapy combined with serplulimab, and chemotherapy as first-line treatment for metastatic p...
October 17, 2026
Medspoke
Medspoke
Blood Advances
Published October 16, 2026
00:00
--:--
Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.
October 17, 2026
Share
Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.
https://www.medspoke.co/channel_journal?id=794&tap_id=15791
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Diabetologia
Published October 16, 2026
Evolving phenotype of newly diagnosed type 2 diabetes: a 15-year population-based comparison.
October 17, 2026
Why are you reporting this TALK?
